CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
March 2023—Qiagen has launched its QIAseq Platform Partnership program and a partnership with Sophia Genetics that will bring together QIAseq reagent technology for next-generation sequencing with the Sophia DDM digital analytics platform. The Platform Partnership program aims to enhance the use and compatibility of QIAseq NGS kits to support secondary analysis and tertiary interpretation workflows offered by other digital data-sharing and analytics companies. The kits are designed for use with any sequencer.
Customers can order QIAseq panels combined with the Sophia DDM, a cloud-based platform that analyzes data from various sources. The partnership will initially support somatic variant detection using QIAseq Targeted DNA Pro panels for homologous recombination repair.
Qiagen, 800-426-8157
Sophia Genetics, 617-982-1210